[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"oxygen-deficiency\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:oxygen-deficiency":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,38,67],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100607445","postoperative-spofio-in-obese-and-non-obese-patients-role-of-stop-bang-100607445",false,"NCT07188649","Postoperative SpO₂\u002FFiO₂ in Obese and Non-Obese Patients: Role of STOP-BANG","Early Postoperative SpO₂\u002FFiO₂ Ratio in Obese and Non-Obese Patients Undergoing Laparoscopic Surgery in the Reverse Trendelenburg Position: Evaluation Together With the STOP-BANG Score","Inclusion Criteria:\n\n* Patients over 18 years old\n* Patients who give consent to participate in the study\n* Patients who underwent elective laparoscopic cholecystectomy in Reverse Trendelenburg (30 degrees) position\n* ASA I-III patients\n* Patients with operation time \\\u003C 3 hours\n\nExclusion Criteria:\n\n* Patients under 18 years old\n* Patients who did not give consent\n* Patients with asthma, COPD, or known respiratory disease\n* Patients whose procedure could not be completed or who had missing data\n* Patients with general anesthesia duration \\\u003C 90 minutes will not be included","ALL","18 Years",{"count":19,"type":20},64,"ESTIMATED","OBSERVATIONAL","The aim of this study is to evaluate the effect of the Reverse Trendelenburg position on oxygenation (SpO₂\u002FFiO₂ ratio) in the early postoperative period in patients undergoing laparoscopic surgery. In our study, obesity is considered as a comparative subgroup in terms of variability of this effect; additionally, the STOP-BANG score, which measures the risk of obstructive sleep apnea syndrome, is examined as an auxiliary indicator.",[24],"Oxygen Deficiency","NOT_YET_RECRUITING","2025-09-16",{"date":28,"type":29},"2025-09-23","ACTUAL",{"date":31,"type":20},"2025-09-25",{"date":33,"type":20},"2026-02-15",{"name":35,"class":36},"Istinye University","OTHER",1,{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":45,"minAge":17,"maxAge":46,"enrollmentInfo":47,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":49,"conditions":50,"keywords":53,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":37},"100552605","tissue-oximetrys-measurement-in-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-100552605","NCT06475261","Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy","Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: Prospective Observational Study With Device","Inclusion Criteria:\n\n* American Society Anesthesiologists (ASA) Classification 1-2\n* Cytoreductive surgery for ovarian cancer with laparoscopic or laparotomic technique with Hypertermic Intraperitoneal Chemotherapy.\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years\n* ASA \\> or = 3\n* Cytoreductive surgery without hyperthermic intraperitoneal chemotherapy","FEMALE","75 Years",{"count":48,"type":20},50,"Tissue oximetry obtained from peripheral muscle measures the state of tissue oxygenation of various organs and, as already widely described in the literature, can be used to measure the state of kidney's tissue oxygenation. However, there is no evidence in the existing scientific literature on the use of muscle tissue oximetry in patients undergoing cytoreductive surgery for ovarian cancer with hyperthermic intraperitoneal chemotherapy.\n\nThe primary objective of our study is to evaluate whether there is a correlation between average intraoperative muscle tissue oximetry below 65% (a value which is considered critical in the literature for the resulting cellular damage) and postoperative renal damage in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for ovarian cancer.",[24,51,52],"Acute Kidney Injury","Ovarian Carcinoma",[54,55,51,56],"Tissue Oximetry","Hyperthermic Intraperitoneal Chemotherapy","Hemodynamics parameters","RECRUITING","2025-03-05",{"date":60,"type":29},"2025-03-07",{"date":62,"type":29},"2024-07-27",{"date":64,"type":20},"2025-09-30",{"name":66,"class":36},"Fondazione Policlinico Universitario Agostino Gemelli IRCCS",{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":4,"eligibilityCriteria":73,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":74,"targetDuration":4,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":82,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":37},"100316177","freedom-innovative-strategy-for-the-management-of-copd-exacerbations-100316177","NCT03396172","FreeDom: Innovative Strategy for the Management of COPD Exacerbations","FreeDom : Innovative Strategy for the Management of COPD Exacerbations Combining Early Hospitalisation Discharge, Automated Oxygen Weaning at Home, Telemedicine and Tele-rehabilitation","Inclusion Criteria:\n\nAll patients hospitalized for COPD exacerbation for less than 48 hours will be considered.\n\n* known or suspected COPD to entry\n* Age \\> or = 40 years\n* Ex-smoker history (10 pack \u002F year or more)\n* Acute Exacerbation: dyspnea of recent onset (less than 15 days)\n* The need for oxygen therapy with a moderate rate: \\\u003C6L \u002F min to maintain SpO2 \\> 90% (for oxygen dependent patient, the oxygen flow must be higher than flow at home)\n\nExclusion Criteria:\n\n* Refusal to consent to participate in the study,\n* Indication for an imminent intubation according to the pulmonologist,\n* Sleep Apnea\n* NIV used at home\n* Lack of FreeO2 system available at the time of randomization\n* Non-autonomous and alone at home\n* Patient alone at home\n* Patients who live more than 50 km from the hospital\n* Patient already included in the study within 3 months",{"count":75,"type":20},100,"INTERVENTIONAL",[78],"NA","The main objective of the study is to assess the \"FreeDom\" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation.\n\nThe main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.",[24,81],"COPD Exacerbation",[83,84,85,86,87,88],"COPD","Homecare","Oxygen","Telemedicine","Automated oxygen adjustment","Rehabilitation program","2024-06-17",{"date":91,"type":29},"2024-06-18",{"date":93,"type":29},"2018-05-24",{"date":95,"type":20},"2025-12",{"name":97,"class":36},"Laval University"]